-
1
-
-
0037362895
-
Expression patterns of protein kinase C isoenzymes are characteristically modulated in chronic pancreatitis and pancreatic cancer
-
Evans JD, Cornford PA, Dodson A, et al. Expression patterns of protein kinase C isoenzymes are characteristically modulated in chronic pancreatitis and pancreatic cancer. Am J Clin Pathol 2003;119(3): 392-402
-
(2003)
Am J Clin Pathol
, vol.119
, Issue.3
, pp. 392-402
-
-
Evans, J.D.1
Cornford, P.A.2
Dodson, A.3
-
2
-
-
84876796439
-
Inflammation, autophagy, and obesity: Common features in the pathogenesis of pancreatitis and pancreatic cancer
-
e1194
-
Gukovsky I, Li N, Todoric J, et al. Inflammation, autophagy, and obesity: common features in the pathogenesis of pancreatitis and pancreatic cancer. Gastroenterology 2013;144(6):1199-209. e1194
-
(2013)
Gastroenterology
, vol.144
, Issue.6
, pp. 1199-1209
-
-
Gukovsky, I.1
Li, N.2
Todoric, J.3
-
3
-
-
79953761842
-
Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression
-
Fukuda A, Wang SC, Morris JP 4th, et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 2011;19(4):441-55
-
(2011)
Cancer Cell
, vol.19
, Issue.4
, pp. 441-455
-
-
Fukuda, A.1
Wang, S.C.2
Morris, I.V.J.P.3
-
4
-
-
77952958193
-
Protein kinase Cvarepsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2)
-
Aziz MH, Hafeez BB, Sand JM, et al. Protein kinase Cvarepsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2). Oncogene 2010;29(21):3100-9
-
(2010)
Oncogene
, vol.29
, Issue.21
, pp. 3100-3109
-
-
Aziz, M.H.1
Hafeez, B.B.2
Sand, J.M.3
-
5
-
-
4444260453
-
PKC-delta and -epsilon regulate NF-kappaB activation induced by cholecystokinin and TNF-alpha in pancreatic acinar cells
-
Satoh A, Gukovskaya AS, Nieto JM, et al. PKC-delta and -epsilon regulate NF-kappaB activation induced by cholecystokinin and TNF-alpha in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol 2004; 287(3):G582-91
-
(2004)
Am J Physiol Gastrointest Liver Physiol
, vol.287
, Issue.3
, pp. G582-G591
-
-
Satoh, A.1
Gukovskaya, A.S.2
Nieto, J.M.3
-
6
-
-
33746784110
-
Ethanol sensitizes NF-kappaB activation in pancreatic acinar cells through effects on protein kinase C-epsilon
-
Satoh A, Gukovskaya AS, Reeve JR Jr, et al. Ethanol sensitizes NF-kappaB activation in pancreatic acinar cells through effects on protein kinase C-epsilon. Am J Physiol Gastrointest Liver Physiol 2006;291(3): G432-8
-
(2006)
Am J Physiol Gastrointest Liver Physiol
, vol.291
, Issue.3
, pp. G432-G438
-
-
Satoh, A.1
Gukovskaya, A.S.2
Reeve, J.R.3
-
7
-
-
0031827507
-
Directed antisense therapy confirms the role of protein kinase C-alpha in the tumorigenicity of pancreatic cancer
-
discussion 223-214
-
Denham DW, Franz MG, Denham W, et al. Directed antisense therapy confirms the role of protein kinase C-alpha in the tumorigenicity of pancreatic cancer. Surgery 1998;124(2):218-23.discussion 223-214
-
(1998)
Surgery
, vol.124
, Issue.2
, pp. 218-223
-
-
Denham, D.W.1
Franz, M.G.2
Denham, W.3
-
8
-
-
42049109067
-
TGF-beta mediates PTEN suppression and cell motility through calcium-dependent PKC-alpha activation in pancreatic cancer cells
-
Chow JY, Dong H, Quach KT, et al. TGF-beta mediates PTEN suppression and cell motility through calcium-dependent PKC-alpha activation in pancreatic cancer cells. Am J Physiol Gastrointest Liver Physiol 2008;294(4):G899-905
-
(2008)
Am J Physiol Gastrointest Liver Physiol
, vol.294
, Issue.4
, pp. G899-905
-
-
Chow, J.Y.1
Dong, H.2
Quach, K.T.3
-
9
-
-
77955191504
-
PKC alpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1
-
Chen Y, Yu G, Yu D, Zhu M. PKC alpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1. J Exp Clin Cancer Res 2010;29:104
-
(2010)
J Exp Clin Cancer Res
, vol.29
, pp. 104
-
-
Chen, Y.1
Yu, G.2
Yu, D.3
Zhu, M.4
-
10
-
-
0036095759
-
A protein kinase C inhibitor induces phenotypic reversion of ras-transformed pancreatic cancer cells and cooperatively blocks tumor cell proliferation with an anti-ras peptide
-
Way D, Smith S, Sivendran S, et al. A protein kinase C inhibitor induces phenotypic reversion of ras-transformed pancreatic cancer cells and cooperatively blocks tumor cell proliferation with an anti-ras peptide. Cancer Chemother Pharmacol 2002;49(6):429-37
-
(2002)
Cancer Chemother Pharmacol
, vol.49
, Issue.6
, pp. 429-437
-
-
Way, D.1
Smith, S.2
Sivendran, S.3
-
11
-
-
0033828604
-
Activation of protein kinase Calpha inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest
-
Detjen KM, Brembeck FH, Welzel M, et al. Activation of protein kinase Calpha inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest. J Cell Sci 2000;113(Pt 17):3025-35
-
(2000)
J Cell Sci
, vol.113
, pp. 3025-3035
-
-
Detjen, K.M.1
Brembeck, F.H.2
Welzel, M.3
-
12
-
-
0038308404
-
Activation of conventional PKC isoforms increases expression of the pro-apoptotic protein Bad and TRAIL receptors
-
Farrow B, Thomas RP, Wang XF, Evers BM. Activation of conventional PKC isoforms increases expression of the pro-apoptotic protein Bad and TRAIL receptors. Int J Gastrointest Cancer 2002; 32(2-3):63-72
-
(2002)
Int J Gastrointest Cancer
, vol.32
, Issue.2-3
, pp. 63-72
-
-
Farrow, B.1
Thomas, R.P.2
Wang, X.F.3
Evers, B.M.4
-
13
-
-
42549158923
-
Protein kinase C: A target for therapy in pancreatic cancer
-
El-Rayes BF, Ali S, Philip PA, Sarkar FH. Protein kinase C: a target for therapy in pancreatic cancer. Pancreas 2008;36(4): 346-52
-
(2008)
Pancreas
, vol.36
, Issue.4
, pp. 346-352
-
-
El-Rayes, B.F.1
Ali, S.2
Philip, P.A.3
Sarkar, F.H.4
-
14
-
-
77951078231
-
Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma
-
Lam AP, Sparano JA, Vinciguerra V, et al. Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma. Am J Clin Oncol 2010;33(2):121-4
-
(2010)
Am J Clin Oncol
, vol.33
, Issue.2
, pp. 121-124
-
-
Lam, A.P.1
Sparano, J.A.2
Vinciguerra, V.3
-
15
-
-
33645453677
-
Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer
-
Paz-Ares L, Douillard JY, Koralewski P, et al. Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2006;24(9):1428-34
-
(2006)
J Clin Oncol
, vol.24
, Issue.9
, pp. 1428-1434
-
-
Paz-Ares, L.1
Douillard, J.Y.2
Koralewski, P.3
-
16
-
-
34248631942
-
Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in in-vitro [corrected] soft-agar cloning experiments
-
Hanauske AR, Oberschmidt O, Hanauske-Abel H, et al. Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in in-vitro [corrected] soft-agar cloning experiments. Invest New Drugs 2007;25(3):205-10
-
(2007)
Invest New Drugs
, vol.25
, Issue.3
, pp. 205-210
-
-
Hanauske, A.R.1
Oberschmidt, O.2
Hanauske-Abel, H.3
-
17
-
-
79151469315
-
Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a phase II, randomized, noncomparative study
-
Richards DA, Kuefler PR, Becerra C, et al. Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: results of a phase II, randomized, noncomparative study. Invest New Drugs 2011;29(1):144-53
-
(2011)
Invest New Drugs
, vol.29
, Issue.1
, pp. 144-153
-
-
Richards, D.A.1
Kuefler, P.R.2
Becerra, C.3
-
18
-
-
84867580010
-
Activation of protein kinase C delta leads to increased pancreatic acinar cell dedifferentiation in the absence of MIST1
-
Johnson CL, Peat JM, Volante SN, et al. Activation of protein kinase C delta leads to increased pancreatic acinar cell dedifferentiation in the absence of MIST1. J Pathol 2012;228(3):351-65
-
(2012)
J Pathol
, vol.228
, Issue.3
, pp. 351-365
-
-
Johnson, C.L.1
Peat, J.M.2
Volante, S.N.3
-
19
-
-
0036327373
-
Enhancement of anchorage-independent growth of human pancreatic carcinoma MIA PaCa-2 cells by signaling from protein kinase C to mitogen-activated protein kinase
-
Ishino K, Fukazawa H, Shikano M, et al. Enhancement of anchorage-independent growth of human pancreatic carcinoma MIA PaCa-2 cells by signaling from protein kinase C to mitogen-activated protein kinase. Mol Carcinog 2002;34(4):180-6
-
(2002)
Mol Carcinog
, vol.34
, Issue.4
, pp. 180-186
-
-
Ishino, K.1
Fukazawa, H.2
Shikano, M.3
-
20
-
-
74049146296
-
PKC Delta (PKCdelta) promotes tumoral progression of human ductal pancreatic cancer
-
Mauro LV, Grossoni VC, Urtreger AJ, et al. PKC Delta (PKCdelta) promotes tumoral progression of human ductal pancreatic cancer. Pancreas 2010;39(1): e31-41
-
(2010)
Pancreas
, vol.39
, Issue.1
, pp. e31-41
-
-
Mauro, L.V.1
Grossoni, V.C.2
Urtreger, A.J.3
-
21
-
-
84920414826
-
Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cdelta activation in pancreatic ductal adenocarcinoma
-
Cheng J, Tian L, Ma J, et al. Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cdelta activation in pancreatic ductal adenocarcinoma. Mol Oncol 2015;9(1): 105-14
-
(2015)
Mol Oncol
, vol.9
, Issue.1
, pp. 105-114
-
-
Cheng, J.1
Tian, L.2
Ma, J.3
-
22
-
-
73549119433
-
Rottlerin stimulates apoptosis in pancreatic cancer cells through interactions with proteins of the Bcl-2 family
-
Ohno I, Eibl G, Odinokova I, et al. Rottlerin stimulates apoptosis in pancreatic cancer cells through interactions with proteins of the Bcl-2 family. Am J Physiol Gastrointest Liver Physiol 2010;298(1): G63-73
-
(2010)
Am J Physiol Gastrointest Liver Physiol
, vol.298
, Issue.1
, pp. G63-73
-
-
Ohno, I.1
Eibl, G.2
Odinokova, I.3
-
23
-
-
84862961434
-
Protein kinase Cdelta inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumors
-
Chen Z, Forman LW, Miller KA, et al. Protein kinase Cdelta inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumors. Endocr Relat Cancer 2011;18(6):759-71
-
(2011)
Endocr Relat Cancer
, vol.18
, Issue.6
, pp. 759-771
-
-
Chen, Z.1
Forman, L.W.2
Miller, K.A.3
-
24
-
-
84893803834
-
Protein kinase C-delta inactivation inhibits the proliferation and survival of cancer stem cells in culture and in vivo
-
Chen Z, Forman LW, Williams RM, Faller DV. Protein kinase C-delta inactivation inhibits the proliferation and survival of cancer stem cells in culture and in vivo. BMC Cancer 2014;14:90
-
(2014)
BMC Cancer
, vol.14
, pp. 90
-
-
Chen, Z.1
Forman, L.W.2
Williams, R.M.3
Faller, D.V.4
-
25
-
-
0031761325
-
Peptide modulators of protein-protein interactions in intracellular signaling
-
Souroujon MC, Mochly-Rosen D. Peptide modulators of protein-protein interactions in intracellular signaling. Nat Biotechnol 1998;16(10):919-24
-
(1998)
Nat Biotechnol
, vol.16
, Issue.10
, pp. 919-924
-
-
Souroujon, M.C.1
Mochly-Rosen, D.2
-
26
-
-
34047158112
-
Rational design of a selective antagonist of epsilon protein kinase C derived from the selective allosteric agonist, pseudo-RACK peptide
-
Liron T, Chen LE, Khaner H, et al. Rational design of a selective antagonist of epsilon protein kinase C derived from the selective allosteric agonist, pseudo-RACK peptide. J Mol Cell Cardiol 2007;42(4): 835-41
-
(2007)
J Mol Cell Cardiol
, vol.42
, Issue.4
, pp. 835-841
-
-
Liron, T.1
Chen, L.E.2
Khaner, H.3
-
27
-
-
0346102817
-
PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells
-
Trauzold A, Schmiedel S, Sipos B, et al. PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells. Oncogene 2003;22(55): 8939-47
-
(2003)
Oncogene
, vol.22
, Issue.55
, pp. 8939-8947
-
-
Trauzold, A.1
Schmiedel, S.2
Sipos, B.3
-
28
-
-
77952134654
-
A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo
-
Harikumar KB, Kunnumakkara AB, Ochi N, et al. A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo. Mol Cancer Ther 2010;9(5):1136-46
-
(2010)
Mol Cancer Ther
, vol.9
, Issue.5
, pp. 1136-1146
-
-
Harikumar, K.B.1
Kunnumakkara, A.B.2
Ochi, N.3
-
29
-
-
0028063391
-
Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta
-
Diaz-Meco MT, Lozano J, Municio MM, et al. Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. J Biol Chem 1994;269(50):31706-10
-
(1994)
J Biol Chem
, vol.269
, Issue.50
, pp. 31706-31710
-
-
Diaz-Meco, M.T.1
Lozano, J.2
Municio, M.M.3
-
30
-
-
77950250455
-
Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis
-
Scotti ML, Bamlet WR, Smyrk TC, et al. Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis. Cancer Res 2010;70(5): 2064-74
-
(2010)
Cancer Res
, vol.70
, Issue.5
, pp. 2064-2074
-
-
Scotti, M.L.1
Bamlet, W.R.2
Smyrk, T.C.3
-
31
-
-
13944253118
-
Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway
-
Leitges M, Sanz L, Martin P, et al. Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol Cell 2001;8(4):771-80
-
(2001)
Mol Cell
, vol.8
, Issue.4
, pp. 771-780
-
-
Leitges, M.1
Sanz, L.2
Martin, P.3
-
32
-
-
0029003788
-
PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid
-
Muller G, Ayoub M, Storz P, et al. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 1995;14(9):1961-9
-
(1995)
EMBO J
, vol.14
, Issue.9
, pp. 1961-1969
-
-
Muller, G.1
Ayoub, M.2
Storz, P.3
-
33
-
-
0028845927
-
Identification of protein kinase C zeta isozyme in hamster pancreas and pancreatic carcinoma cell lines
-
Nair SC, Pour PM, Lawson T, et al. Identification of protein kinase C zeta isozyme in hamster pancreas and pancreatic carcinoma cell lines. Mol Carcinog 1995; 14(3):205-13
-
(1995)
Mol Carcinog
, vol.14
, Issue.3
, pp. 205-213
-
-
Nair, S.C.1
Pour, P.M.2
Lawson, T.3
-
34
-
-
84883178112
-
Protein kinase C zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent mechanism
-
Butler AM, Scotti Buzhardt ML, Li S, et al. Protein kinase C zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent mechanism. PLoS One 2013;8(8):e72061
-
(2013)
PLoS One
, vol.8
, Issue.8
, pp. e72061
-
-
Butler, A.M.1
Scotti Buzhardt, M.L.2
Li, S.3
-
35
-
-
84884701740
-
APKClambda/iota is a beneficial prognostic marker for pancreatic neoplasms
-
Kato S, Akimoto K, Nagashima Y, et al. aPKClambda/iota is a beneficial prognostic marker for pancreatic neoplasms. Pancreatology 2013;13(4):360-8
-
(2013)
Pancreatology
, vol.13
, Issue.4
, pp. 360-368
-
-
Kato, S.1
Akimoto, K.2
Nagashima, Y.3
-
36
-
-
68949119575
-
Identification of 3-hydroxy-2-(3-hydroxyphenyl)-4H-1-benzopyran-4-ones as isoform-selective PKC-zeta inhibitors and potential therapeutics for psychostimulant abuse
-
Yuan L, Seo JS, Kang NS, et al. Identification of 3-hydroxy-2-(3-hydroxyphenyl)-4H-1-benzopyran-4-ones as isoform-selective PKC-zeta inhibitors and potential therapeutics for psychostimulant abuse. Mol Biosyst 2009;5(9):927-30
-
(2009)
Mol Biosyst
, vol.5
, Issue.9
, pp. 927-930
-
-
Yuan, L.1
Seo, J.S.2
Kang, N.S.3
-
37
-
-
77952242326
-
Screening of a PKC zeta-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxis
-
Wu J, Zhang B, Wu M, et al. Screening of a PKC zeta-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxis. Invest New Drugs 2010;28(3):268-75
-
(2010)
Invest New Drugs
, vol.28
, Issue.3
, pp. 268-275
-
-
Wu, J.1
Zhang, B.2
Wu, M.3
-
38
-
-
84875617207
-
Adenosine-binding motif mimicry and cellular effects of a thieno [2,3-d] pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes
-
Kjaer S, Linch M, Purkiss A, et al. Adenosine-binding motif mimicry and cellular effects of a thieno [2,3-d] pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes. Biochem J 2013;451(2):329-42
-
(2013)
Biochem J
, vol.451
, Issue.2
, pp. 329-342
-
-
Kjaer, S.1
Linch, M.2
Purkiss, A.3
-
39
-
-
58549114487
-
2-(6- Phenyl-1H-indazol-3-yl)-1H-benzo[d] imidazoles: Design and synthesis of a potent and isoform selective PKC-zeta inhibitor
-
Trujillo JI, Kiefer JR, Huang W, et al. 2-(6- Phenyl-1H-indazol-3-yl)-1H-benzo[d] imidazoles: design and synthesis of a potent and isoform selective PKC-zeta inhibitor. Bioorg Med Chem Lett 2009;19(3):908-11
-
(2009)
Bioorg Med Chem Lett
, vol.19
, Issue.3
, pp. 908-911
-
-
Trujillo, J.I.1
Kiefer, J.R.2
Huang, W.3
-
40
-
-
80053931055
-
4-benzimidazolyl-3-phenylbutanoic acids as novel PIF-pocket-targeting allosteric inhibitors of protein kinase PKCzeta
-
Frohner W, Lopez-Garcia LA, Neimanis S, et al. 4-benzimidazolyl-3-phenylbutanoic acids as novel PIF-pocket-targeting allosteric inhibitors of protein kinase PKCzeta. J Med Chem 2011;54(19):6714-23
-
(2011)
J Med Chem
, vol.54
, Issue.19
, pp. 6714-6723
-
-
Frohner, W.1
Lopez-Garcia, L.A.2
Neimanis, S.3
-
41
-
-
84906092136
-
Discovery and optimization of 1,3,5-trisubstituted pyrazolines as potent and highly selective allosteric inhibitors of protein kinase C-zeta
-
Abdel-Halim M, Diesel B, Kiemer AK, et al. Discovery and optimization of 1,3,5-trisubstituted pyrazolines as potent and highly selective allosteric inhibitors of protein kinase C-zeta. J Med Chem 2014; 57(15):6513-30
-
(2014)
J Med Chem
, vol.57
, Issue.15
, pp. 6513-6530
-
-
Abdel-Halim, M.1
Diesel, B.2
Kiemer, A.K.3
-
42
-
-
36749037936
-
Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer
-
Fields AP, Frederick LA, Regala RP. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer. Biochem Soc Trans 2007; 35(Pt 5):996-1000
-
(2007)
Biochem Soc Trans
, vol.35
, pp. 996-1000
-
-
Fields, A.P.1
Frederick, L.A.2
Regala, R.P.3
-
43
-
-
84885390091
-
Phase i dose escalation study of the PKCiota inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer
-
Mansfield AS, Fields AP, Jatoi A, et al. Phase I dose escalation study of the PKCiota inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer. Anticancer Drugs 2013;24(10):1079-83
-
(2013)
Anticancer Drugs
, vol.24
, Issue.10
, pp. 1079-1083
-
-
Mansfield, A.S.1
Fields, A.P.2
Jatoi, A.3
-
44
-
-
79955828776
-
Stromal biology and therapy in pancreatic cancer
-
Neesse A, Michl P, Frese KK, et al. Stromal biology and therapy in pancreatic cancer. Gut 2011;60(6):861-8
-
(2011)
Gut
, vol.60
, Issue.6
, pp. 861-868
-
-
Neesse, A.1
Michl, P.2
Frese, K.K.3
-
45
-
-
45549086211
-
K-Ras-driven pancreatic cancer mouse model for anticancer inhibitor analyses
-
Cook N, Olive KP, Frese K, Tuveson DA. K-Ras-driven pancreatic cancer mouse model for anticancer inhibitor analyses. Methods Enzymol 2008;439:73-85
-
(2008)
Methods Enzymol
, vol.439
, pp. 73-85
-
-
Cook, N.1
Olive, K.P.2
Frese, K.3
Tuveson, D.A.4
-
46
-
-
0026747279
-
Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue
-
Fu X, Herrera H, Hoffman RM. Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue. Int J Cancer 1992;52(6):987-90
-
(1992)
Int J Cancer
, vol.52
, Issue.6
, pp. 987-990
-
-
Fu, X.1
Herrera, H.2
Hoffman, R.M.3
-
47
-
-
84900029102
-
Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX)
-
Hiroshima Y, Zhao M, Maawy A, et al. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX). J Cell Biochem 2014;115(7): 1254-61
-
(2014)
J Cell Biochem
, vol.115
, Issue.7
, pp. 1254-1261
-
-
Hiroshima, Y.1
Zhao, M.2
Maawy, A.3
-
48
-
-
84859992000
-
Multi-color palette of fluorescent proteins for imaging the tumor microenvironment of orthotopic tumorgraft mouse models of clinical pancreatic cancer specimens
-
Suetsugu A, Katz M, Fleming J, et al. Multi-color palette of fluorescent proteins for imaging the tumor microenvironment of orthotopic tumorgraft mouse models of clinical pancreatic cancer specimens. J Cell Biochem 2012;113(7):2290-5
-
(2012)
J Cell Biochem
, vol.113
, Issue.7
, pp. 2290-2295
-
-
Suetsugu, A.1
Katz, M.2
Fleming, J.3
-
49
-
-
84865692156
-
Non-invasive fluorescent-protein imaging of orthotopic pancreatic-cancer-patient tumorgraft progression in nude mice
-
Suetsugu A, Katz M, Fleming J, et al. Non-invasive fluorescent-protein imaging of orthotopic pancreatic-cancer-patient tumorgraft progression in nude mice. Anticancer Res 2012;32(8):3063-7
-
(2012)
Anticancer Res
, vol.32
, Issue.8
, pp. 3063-3067
-
-
Suetsugu, A.1
Katz, M.2
Fleming, J.3
-
50
-
-
84859952919
-
Imageable fluorescent metastasis resulting in transgenic GFP mice orthotopically implanted with human-patient primary pancreatic cancer specimens
-
Suetsugu A, Katz M, Fleming J, et al. Imageable fluorescent metastasis resulting in transgenic GFP mice orthotopically implanted with human-patient primary pancreatic cancer specimens. Anticancer Res 2012;32(4):1175-80
-
(2012)
Anticancer Res
, vol.32
, Issue.4
, pp. 1175-1180
-
-
Suetsugu, A.1
Katz, M.2
Fleming, J.3
|